FDA Clearance Tracker · P180013-S005
VICI VENOUS STENT System
Last checked: Nov 20, 2026Latest source record: May 26, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 26, 2020
Approved
Time to decision
47 days
Received Apr 9, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180013-S005
- Device name
- VICI VENOUS STENT System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marborough, MA
- Received
- Apr 9, 2020
- Decided
- May 26, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P180013
Device type
- Device type
- Stent, iliac vein (QAN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.